IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C-Reference-Cited by-同舟云学术

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C

Published:2012-03 Issue:3 Volume:56 Page:527-532
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Asselah Tarik,De Muynck Simon,Broët Philippe,Masliah-Planchon Julien,Blanluet Maud,Bièche Ivan,Lapalus Martine,Martinot-Peignoux Michelle,Lada Olivier,Estrabaud Emilie,Zhang Qian,El Ray Ahmed,Vidaud Dominique,Ripault Marie-Pierre,Boyer Nathalie,Bedossa Pierre,Valla Dominique,Vidaud Michel,Marcellin Patrick

Publisher

Elsevier BV

Subject

Hepatology

Reference29 articles.

1. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report;Antaki;Liver Int,2010

2. Hepatitis C virus genotype 4 therapy: progress and challenges;Kamal;Liver Int,2011

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

5. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin;Bronowicki;Gastroenterology,2006

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Elimination in Egypt: Story of Success;Pathogens;2024-08-12

2. Cytokine polymorphisms and genotypic susceptibility of HCV infection in ribavirin response to peg interferon;Tropical Biomedicine;2023-09-30

3. Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients;Medicine;2023-07-14

4. Favorable Genotypes of Type III Interferon Confer Risk of Dyslipidemia in the Population With Obesity;Frontiers in Endocrinology;2022-06-16

5. Case study of hepatitis C virus control in Egypt: impact of access program;Antiviral Therapy;2022-04